跳至主要内容
临床试验/NCT06264024
NCT06264024招募中不适用

Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2024年2月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
81
试验地点
1
主要终点
Risk of progression

研究概览

简要总结

The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK.

The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
  • Progressive keratoconus with indication for CXL
  • Corneal thickness ≥ 420 μm

排除标准

  • Other eye disease causing visual impairment

结局指标

主要结局

Risk of progression

时间窗: 1 year after surgery

Change in keratometric values

Visual acuity

时间窗: 1 month after surgery

Uncorrected and corrected distance visual acuity in logMAR

次要结局

  • Visual acuity(5 years after surgery)
  • Depth of demarcation line (confocal microscopy)(1 month after surgery)
  • Patient reported outcome measure (PROMs)(2 years after surgery)
  • Risk of progression(5 years after surgery)
  • Depth of demarcation line (OCT)(1 month after surgery)
  • Patient reported pain after surgery(48 hours after surgery)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Olav Kristianslund

MD, PhD

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验